~" The purpose of this study was to determine the cause of the loss of endothelium-dependent relaxation observed in chronic cerebral vasospasm. A bioassay system was developed to measure the release of endothelium-derived relaxing factor (EDRF) from canine basilar arteries. Subarachnoid hemorrhage (SAH) was induced in dogs by two injections of autologous blood into the cisterna magna. Angiograms were performed on the 7th day after SAH to check the presence of chronic vasospasm. The animals were sacrificed on the 8th day, and in vitro experiments were performed on rings harvested from the basilar artery. These confirmed loss of endothelium-dependent relaxation in response to bradykinin and arginine vasopressin in the group with SAH. The basilar arteries were perfused with modified Krebs-Ringer solution. The perfusate was bioassayed with a ring of coronary artery without endothelium (bioassay ring). The release of the EDRF was detected by relaxation of the bioassay ring contracted with prostaglandin F2~. Arginine vasopressin and bradykinin added to the perfusate upstream of the basilar artery caused concentration-dependent release of the EDRF. The direct effect of these peptides on the smooth muscle of the bioassay ring was to cause contraction. The release of the EDRF was identical in basilar arteries from the control and the SAH groups. These results indicate that the release of the EDRF is not impaired during chronic vasospasm, and thus that the loss of the endotheliumdependent relaxation is due to a decreased transfer of the EDRF or a reduced responsiveness of the smooth muscle to the factor.
NDOTHELIUM-DEPENDENT relaxation is abolished
in the canine basilar artery during chronic vasospasm after subarachnoid hemorrhage (SAH). ~7. 8 The present study was undertaken to determine the cause of the observed loss of endothelium-dependent relaxation. Bioassay experiments 726 were performed to examine whether the loss is due to reduced release of endothelium-derived relaxing factor (EDRF) or to alterations in sensitivity of vascular smooth muscle to the factor.
Materials and Methods

Study Groups
Fourteen mongrel dogs of either sex, each weighing 15 to 25 kg, were used for this study. The animals were randomly allocated to a control group and a group to receive SAH. In the SAH group, autologous venous blood (5 to 6 ml) was injected percutaneously into the cisterna magna twice with a 2-day interval. 29 Transfemoral angiography with iothalamate meglumine (Conray) was performed prior to the initial injection of blood and l week later, to confirm the presence or absence of vasospasm in the basilar artery. The angiograms and cisternal injections of blood were performed under general anesthesia (pentobarbital, 15 to 25 mg/ kg, and thiopental, 15 mg/kg, administered intravenously) and controlled ventilation. In the control group, only transfemoral angiography was performed. During the angiogram, arterial blood gases were monitored to rule out the influence of variation in pCO2. The diameter and cross-sectional area of the basilar artery was measured by a computer-connected digitization system. The resolution and range of error of the system are described elsewhere.~924 Eight days after the first injection of blood, animals were sacrificed with an intravenous injection of sodium pentobarbital (30 mg/kg) and exsanguination. The brain and the heart were dissected free. All procedures were performed on control and SAH animals in parallel. The procedures and the han-Release of endothelium-derived relaxing factor dling of the animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Mayo Foundation.
Isometric Tension Recording
With the aid of a stereoscopic microscope, the basilar arteries were dissected free of the brain stem, and the subarachnoid clot, if present, was removed. Rings for the measurement of isometric tension were prepared from the cephalad portion of the basilar artery. In some rings, the endothelium was mechanically removed by gentle rubbing of the intimal surface with a stainless steel wire. TM The arterial rings were connected to an isometric force transducer* with two triangular stainless steel wire stirrups (0.035 gauge) inserted in the lumen, and suspended in an organ chamber filled with modified Krebs-Ringer bicarbonate solution (composition (mM): NaC1 118.3, KCI 4.7, CaC12 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0, Ca ethylenediaminetetraacetic acid 0.026, and glucose 11.1), hereafter referred to as "the control solution," maintained at 37"C and bubbled with a 95% 02/5% CO2 gas mixture. The rings were initially equilibrated for 30 minutes at a length where the tension was 100 mg. This length is referred to as "the initial length." The rings were then stretched to the optimal point of their length-tension relationship, and responses to 40 mM KC1 were measured at each increment of length (0.2 mm, stepwise). Responses to arginine vasopressin (10 -ll to 10 -7 M) and bradykinin (10 -j~ to 10 -6 M) were measured during contractions caused by uridine 5'-triphosphate (3 x 10 -6 M, which corresponds to the EDs0 for contractions in both groups 17) in the absence or presence of indomethacin (I0 -5 M). Responses in the presence of indomethacin were measured after 30 minutes of incubation with the inhibitor of cyclo-oxygenase.
Bioassay of Endothelium-Derived Relaxing Factor
Experiments were carried out in parallel on pairs of basilar arteries from an animal in the control group and in the SAH group. Basilar artery segments (about 40 to 45 mm long) were prepared under a stereoscopic microscope. The residual blood in the lumen of the artery was washed out by gentle irrigation with Krebs-Ringer solution using a No. 25 needle connected to a tuberculin syringe. In the SAH group, the clot on the surface of the artery was removed carefully so that all of the perforating branches of the basilar artery were preserved. The branches of the basilar arteries were ligated (35 to 45 ligations per segment) with 10-0 silk suture, and some small perforators were cauterized with an electrocautery under the microscope to obtain a segment free of leaks. The segments were cannulated at both ends with stainless steel cannulas (outer diameter 1.07 mm for the control group, 0.71 mm for the SAH group) then suspended in an organ bath maintained at * Isometric force transducer, Model UC-2, manufactured by Gould, Inc., Cleveland, Ohio.
37"C and idled with 15 ml of aerated (95% 02/5% CO2) control solution (Fig. 1) . The solution contained indomethacin (10 -5 M) to prevent prostaglandin formation. The basilar arteries were perfused at constant flow (1 ml/min) by means of a roller pump with control solution containing indomethacin 00 -5 M), maintained at 37"C with heat exchanging coils (arterial line). A stainless steel tube was placed parallel to the artery segment in the organ bath, through which control solution was perfused at the same rate (direct line). The flow rate of the perfusate was monitored occasionally during the experiment to maintain precisely the same rate between the direct line and the arterial line. The temperature of the perfusate was monitored during the experiment by means of an electric thermoprobe.t Two adjacent rings (4 mm wide) of the left circumflex coronary artery were obtained from the heart of the control animal. The endothelium was removed by gentle mechanical rubbing of the lumen of the rings? The ring of coronary artery (the "bioassay ring") was suspended underneath the outlet of the stainless steel cannula below the organ chamber by means of two stainless steel triangular stirrups passed through the lumen, one of which was connected to an isometric force transducer.~t Changes in isometric tension in the bioassay rings were recorded. The assembly of the bioassay rings, stirrups, and force transducer could be moved below the organ chamber, thus allowing the bioassay ring to be superfused with the perfusate either from the basilar artery segment (endothelial superfusion) or from the stainless steel cannula and the Silastic tube (direct superfusion). Before perfusion through the basilar arteries was begun, the bioassay ring was initially superfused for 60 minutes with control solution passing through a Silastic tube suspended in the organ chamber (Fig. l) . After the initial equilibration, the bioassay rings were stretched in a step-wise manner until the basal tension reached 10 gm, which corresponds to the optimal tension for coronary artery rings. 2 During this period, the basilar arteries (mounted on the stainless steel cannulas) were kept immersed in control solution and stored in a refrigerator (4"C) in order to minimize the perfusion time and mechanical damage to the intima. Once the optimal basal tension was reached, prostaglandin (PG) F2, (4 x 10 -6 M) was added to the perfusate. When the contraction of the bioassay ring to PGF2, had reached steady state, arginine vasopressin and subsequently bradykinin were infused through the Silastic tube by an infusion pumpw at a rate of 0.05 ml/min to achieve a final concentration in the perfusate of 10 -7 M for arginine vasopressin and 10 -6 M for bradykinin. Responses of the bioassay ring to these agents during contractions to PGF2. (4 • 10 -6 M) were checked to confirm the absence of endothelium and to determine the direct responses of the vascular smooth muscle to these agents. The Silastic tube and the stainless steel cannula in the organ chamber were then replaced with the basilar artery segment and the stainless steel cannula, and arterial perfusion was started. After the replacement, to safeguard against variation in flow rate, the bioassay ring was again equilibrated with the direct perfusion from the stainless steel cannula. Subsequently, the bioassay ring was moved underneath the arterial line and the basal release of EDRF was measured by the amount of change in tension upon starting endothelial superfusion. Infusion of arginine vasopressin (10 -9 to 10 -7 M) and bradykinin (10 -8 to 10 -6 M ) was repeated through the arterial segment, and the effect of these agents on the release of the EDRF was measured by the amount of change in tension of the ring. At the end of the perfusion experiment, sodium nitroprusside (10 -6 M) was added through the direct line.
Drugs
The following drugs were used; arginine vasopressin, bradykinin (acetate salt), indomethacin, papaverine hydrochloride, PGF2,, sodium nitroprusside, and uridine 5'-triphosphate. The concentrations of drugs are expressed as final molar (M) in the perfusate or the solution in the organ chamber.
Statistical Analysis
The data were expressed as the mean _+ standard error of the mean. Relaxation of basilar artery tings contracted to PGF2, were expressed as percent changes in isometric tension compared to the maximal relaxation to papaverine (10 -4 M). Release of EDRF was expressed as relaxation of the bioassay ring, as a percentage of the maximal relaxation evoked by 10 -6 M FIG. 1. Schematic illustration of the bioassay system for analysis of endothelium-derived relaxing factor released from the basilar artery. See text for the measuring procedure. P. Kim, et al. sodium nitroprusside. Statistical comparisons between groups were made using Student's t-test, and p values smaller than 0.05 were considered to be significant.
Results
Angiography
In the experimental group of animals, the angiograms of the basilar artery performed on the 7th day after SAH showed marked narrowing of the segment; the ratio of the cross-sectional area observed on the 7th day to that observed before the injections of blood was 32% _+ 6.9% (seven dogs). In the control group, the corresponding ratio averaged 114% _+ 13.4% (seven dogs). The difference between the two groups was statistically significant.
Isometric Tension Recordings in Arterial Rings
Arginine vasopressin (10-" to 10 -7 M) caused concentration-dependent, endothelium-dependent relaxation in rings with endothelium from the control group (Fig. 2 left) . Relaxation was absent in rings with endothelium from the SAH group. The endothelium-dependent relaxation in response to vasopressin was not affected by the presence of indomethacin (Fig. 2 left) .
In rings without endothelium, arginine vasopressin caused no changes in tension in the control group and moderate concentration-dependent contractions in the SAH group (Fig. 3 left) .
Bradykinin (10 -1' to 10 -6 M) caused concentrationdependent relaxation in tings with endothelium in the control group ( Fig. 2 right) ; the relaxations were not seen in the tings without endothelium (Fig. 3 right) . In rings with endothelium from the SAH group, no relaxations were observed. The presence of indomethacin did not significantly affect the response to bradykinin (Fig. 2 right) .
Bioassay
After the bioassay rings were contracted with PGF2,~ (4 x 10 -6 M), arginine vasopressin (10 -7 M) was applied to the direct superfusion line (Table 1) . In all bioassay rings, a moderate contraction was observed. Similarly, the addition of bradykinin (10 -6 M ) to the direct line resulted in contractions of the bioassay ring (Table 1) . On the perfusion being switched from the direct line to the endothelial line, relaxation of the bioassay ring was noted (Fig. 4) ; these results were not significantly different in the arteries obtained from the control and the SAH groups (Table 1) .
Arginine vasopressin (10 -9 to 10 -7 M) added to the perfusate upstream from the basilar artery caused concentration-dependent relaxation of the bioassay tings (Fig. 5 left) . No significant difference in relaxation was observed between the control arteries and those from the SAH group. To account for the direct effect of the agonist on the smooth muscle, the relaxation of the bioassay ring observed during arterial perfusion with Release of endothelium-derived relaxing factor 10 -7 M vasopressin was subtracted from the contraction observed during the direct perfusion with the same concentration of the hormone. The subtracted amplitude of responses was comparable in the control and the SAH groups (Fig. 6) .
Bradykinin (10 -8 to 10 -6 M) given upstream of the basilar arteries caused concentration-dependent relaxations of the bioassay rings; the concentration-response curves were similar in both groups (Fig. 5 right) . The subtracted responses to bradykinin were also comparable in the two groups (Fig. 6) .
Discussion
The major experimental findings of the present study were: 1) endothelium-dependent relaxations to arginine vasopressin or bradykinin were abolished in vasospastic basilar arteries; 2) the endothelium-dependent relaxations were not restored in the SAH group by inhibition of cyclo-oxygenase; and 3) the release of EDRF, both under basal conditions and in response to bradykinin and arginine vasopressin, was normal in vasospastic basilar arteries after SAH.
A loss of endothelium-dependent relaxation in cerebral arteries after experimental SAH has been demonstrated both in the rabbit and in the dog. 17'18'23'25 Endothelium-dependent relaxation due to acetylcholine and adenosine triphosphate is abolished in the rabbit basilar artery after injection of blood into the subarachnoid space. 23 Similarly in the dog, endothelium-dependent relaxation induced by arginine vasopressin and thrombin is absent during chronic vasospasm (confirmed angiographically); a positive correlation exists between the degree of loss of endothelium-dependent responses and the degree of angiographic narrowing. 17.18 Bradykinin is one of the most potent agents causing endothelium-dependent relaxation. 6 The present organ chamber experiments confirmed that this agent causes endothelium-dependent relaxation in the canine basilar artery ~3 and demonstrate that these relaxations, similar P. Kim, et al. to those evoked by arginine vasopressin, are abolished during vasospasm after SAH. In both cases, the relaxation seen in the control blood vessels is not mediated by prostacyclin or other cyclo-oxygenase products, as they are not affected by indomethacin. The bioassay experiments were also carried out in the presence of indomethacin to avoid influence of concomitant prostaglandin formation in either the perfused basilar artery or the bioassay ring. Agents that cause endothelium-dependent relaxation can evoke the concomitant release of vasoconstrictor prostaglandins from the endothelium, which then inhibit some degree of the endothelium-dependent relaxation. ~ ~''6'2' The fact that no endothelium-dependent relaxation was observed in vasospastic arteries incubated with indomethacin demonstrates that the concomitant release of prostanoids is not responsible for the loss of endothelium-dependent relaxation.
In contrast to the abolition of endothelium-dependent relaxation, endothelium-dependent contractions in response to acetylcholine, adenosine diphosphate, arachidonic acid, the calcium ionophore A23187, ]~ hypoxia,'5 and mechanical stretch ]2 are all preserved after SAH. 17'~8 These observations imply that the loss of endothelium-dependent relaxation in cerebral vasospasm is not the result of destruction of the endothelium. In studies in the rabbit, Nakagomi, et al., 23 found that endothelial cells were still present, although endothelium-dependent relaxation was absent after SAH; electron microscopy revealed only the loss of tight junctions between the endothelial cells, although the cells remained adherent to the intimal layer. Thus, loss of endothelium-dependent relaxations must be due (alone or in combination) to either a reduced release of the EDRF, a decreased transfer of the EDRF, or a reduced responsiveness of the smooth muscle to the factor.
The present results demonstrate that the ability of endothelial cells to release relaxing factor is unaltered after SAH. The basal release of the EDRF was comparable in the control and the SAH groups. Similarly, the evoked release of EDRF by arginine vasopressin and bradykinin was comparable in both groups. The bioassay experiments reported here measured only the release of the EDRF in the lumen (luminal release). The direction of release, which probably is physiologically more important, is toward the underlying smooth muscle (abluminal release).1 The present results cannot rule out the possibility that the abluminal release of the EDRF is selectively suppressed by the SAH, with the luminal release maintained. However, the earlier finding that endothelium-dependent contractions are maintained after SAH'7-18 makes such a unilateral disorder of the endothelial ceils unlikely.
Hemoglobin inhibits endothelium-dependent relaxations in systemic 23 as well as cerebral arteries. 5 Hemoglobin is present in the subarachnoid space after the injections of blood, and blood components are present in the vasospasfic arterial wall. 2~ Sodium nitroprusside is known to cause relaxation by activation of guanylate cyclase l~ (a mechanism shared with the EDRF6'8), and relaxation induced by the agent is also suppressed by the presence of hemoglobin. 22 Previous work has demonstrated that relaxation evoked by sodium nitroprusside is only slightly reduced by SAH, in marked contrast to abolition of endothelium-dependent relaxations.17 In fact, the maximal relaxations in response to sodium nitroprusside and to papaverine were not affected by the disease process. J7 Therefore, it appears difficult to explain the observed loss of endothelium-dependent relaxation solely by the inactivation of EDRF by the hemoglobin present in the tissue, or by irreversible damage of the relaxation mechanism of the contractile apparatus in the smooth muscle. If this interpretation is correct, and if the endothelial cells do release a normal amount of EDRF toward the underlying smooth muscle, the remaining logical explanation for the loss of endothelium-dependent relaxations during vasospasm is either of the following: 1) morphological damage to the vasospastic arteries 4'9'27'28 introduced a major diffusion barrier to the EDRF, or 2) metabolic coupling between the EDRF and guanylate cyclase in the smooth muscle was disrupted due to damage in the vasculature.
